Key result
Primates, including humans immunized with R-MuLV, demonstrated the ability to form antibodies to well-characterized proteins from endogenous and exogenous type-C viruses.
Population
16 clinically normal gibbons, 4 experimentally inoculated gibbons, 1 woolly monkey, 20 human patients, and…
Design
Preclinical
Authors
Loading...
May support seroepidemiologic studies of type-C viruses; leaves open human clinical relevance pending validation.
Observational
Primates, including humans, can form antibodies to well-characterized proteins from endogenous and exogenous type-C viruses, suggesting utility for seroepidemiologic studies.
Charman et al. (1975) conducted an observational in Exposure to or immunization against type-C viruses. Exposure to or immunization with type-C RNA tumor viruses was evaluated on Formation of antibodies to type-C virus proteins. Primates, including humans immunized with R-MuLV, demonstrated the ability to form antibodies to well-characterized proteins from endogenous and exogenous type-C viruses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: